Author Archives: Warren Woessner

“We Don’t Need No Stinkin’ Patents” – Antibiotic and Antifungal Drugs Gain Non-Patent Exclusivity

Posted on June 23, 2014 by Warren Woessner

Posted on the FDA Law Blog by Kurt Karst on June 19, 2014. After years of relative quiet, the Orange Book list of exclusivity terms has gotten quite a workout over the past year with the addition of several new terms … Continue reading →

Posted in Hatch-Waxman | Tagged , , , , , , | Leave a comment

CLS v Alice – Abstract Idea, Wherefore Art Thou?

Posted on June 19, 2014 by Warren Woessner

Guest post from Brad Forrest, Shareholder at Schwegman Lundberg & Woessner, P.A. Passing on the opportunity to provide a usable test to determine what is an “abstract idea,” the Supreme court simply compared the idea underlying the claims in Alice … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , | 2 Comments

Former SLW Officer Named USPTO Regional Director

Posted on June 17, 2014 by Warren Woessner

Russell Slifer, a former officer at Schwegman Lundberg & Woessner, has been named as the USPTO Regional Director for its Denver office. Michelle Lee, Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the USPTO, wrote on her blog … Continue reading →

Posted in People | Tagged , , , , , , | Leave a comment

Natural Products Eligibility Guidance – Post-Forum Comments

Posted on June 17, 2014 by Warren Woessner

Guest Post from Paul Cole, Lucas & Co., UK Readers of this and other blogs will have been aware of comments of mine in relation to the USPTO natural product eligibility guidance. Available here is the final version of the post-forum comments … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , | Leave a comment